Increased oxidative stress in patients with congestive heart failure
M Keith,
A Geranmayegan,
MJ Sole,
R Kurian,
A Robinson,
AS Omran,
and
KN Jeejeebhoy
Toronto Hospital, Centre for Cardiovascular Research, Ontario, Canada.
OBJECTIVES: We sought to study the markers of lipid peroxidation and defenses against oxidative stress in patients with varying degrees of heart failure. BACKGROUND: Despite advances in other areas of cardiovascular disease, the morbidity and mortality from congestive heart failure (CHF) are increasing. Data mainly from animal models suggest that free radical injury may promote myocardial decompensation. However, there are no studies in humans correlating the severity of heart failure with increased free radical injury and antioxidants. METHODS: Fifty-eight patients with CHF and 19 control subjects were studied. In addition to complete clinical and echocardiographic evaluations, the prognosis of these patients was established by measuring the levels of soluble tumor necrosis factor-alpha receptors 1 and 2 (sTNF-R1 and sTNF-R2). Oxidative stress was evaluated by measuring plasma lipid peroxides (LPO), malondialdehyde (MDA), glutathione peroxidase (GSHPx) and vitamin E and C levels. RESULTS: The patients' age range, cause of heart failure and drug intake were comparable across the different classes of heart failure. Heart failure resulted in a significant increase in LPO (p < 0.005), MDA (p < 0.005), sTNF-R1 (p < 0.005) and sTNF-R2 (p < 0.005). There was a significant positive correlation between the clinical class of heart failure and LPO, MDA, sTNF-R1 and sTNF-R2 levels. There was an inverse correlation between GSHPx and LPO. With increased lipid peroxidation in patients with CHF, the levels of vitamin C decreased, but vitamin E levels were maintained. CONCLUSIONS: These data demonstrate a progressive increase in free radical injury and encroachment on antioxidant reserves with the evolution of heart failure; they also suggest that oxidative stress may be an important determinant of prognosis. The therapeutic benefit of administering antioxidant supplements to patients with CHF should be evaluated.
This article has been cited by other articles:

|
 |

|
 |
 
A. N. Chandrakala, D. Sukul, K. Selvarajan, C. Sai-Sudhakar, B. Sun, and S. Parthasarathy
Induction of brain natriuretic peptide and monocyte chemotactic protein-1 gene expression by oxidized low-density lipoprotein: relevance to ischemic heart failure
Am J Physiol Cell Physiol,
January 1, 2012;
302(1):
C165 - C177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Cole, A. P. Kalogeropoulos, V. V. Georgiopoulou, M. Gheorghiade, A. Quyyumi, C. Yancy, and J. Butler
Hydralazine and Isosorbide Dinitrate in Heart Failure: Historical Perspective, Mechanisms, and Future Directions
Circulation,
May 31, 2011;
123(21):
2414 - 2422.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tuunanen and J. Knuuti
Metabolic remodelling in human heart failure
Cardiovasc Res,
May 1, 2011;
90(2):
251 - 257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kobayashi, T. Susa, T. Tanaka, Y. Wada, S. Okuda, M. Doi, T. Nao, Y. Yoshiga, J. Yamada, T. Okamura, et al.
Urinary 8-hydroxy-2'-deoxyguanosine reflects symptomatic status and severity of systolic dysfunction in patients with chronic heart failure
Eur J Heart Fail,
January 1, 2011;
13(1):
29 - 36.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Rychli, A. Niessner, P. J. Hohensinner, K. M. Ali, C. Kaun, S. Neuhold, G. Zorn, B. Richter, M. Hulsmann, R. Berger, et al.
Prognostic Value of Pigment Epithelium-Derived Factor in Patients With Advanced Heart Failure
Chest,
September 1, 2010;
138(3):
656 - 664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Xie, J. Terrand, B. Xu, G. Tsaprailis, J. Boyer, and Q. M. Chen
Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation
Cardiovasc Res,
September 1, 2010;
87(4):
628 - 635.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Qin, S. Lennon-Edwards, S. Lancel, A. Biolo, D. A. Siwik, D. R. Pimentel, G. W. Dorn, Y. J. Kang, and W. S. Colucci
Cardiac-Specific Overexpression of Catalase Identifies Hydrogen Peroxide-Dependent and -Independent Phases of Myocardial Remodeling and Prevents the Progression to Overt Heart Failure in G{alpha}q-Overexpressing Transgenic Mice
Circ Heart Fail,
March 1, 2010;
3(2):
306 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Koba, Z. Gao, and L. I. Sinoway
Oxidative stress and the muscle reflex in heart failure
J. Physiol.,
November 1, 2009;
587(21):
5227 - 5237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Klosinska, T. Rudzinski, P. Grzelak, L. Stefanczyk, J. Drozdz, and M. Krzeminska-Pakula
Endothelium-dependent and -independent vasodilation is more attenuated in ischaemic than in non-ischaemic heart failure
Eur J Heart Fail,
August 1, 2009;
11(8):
765 - 770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pavoine and F. Pecker
Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology
Cardiovasc Res,
May 1, 2009;
82(2):
175 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al.
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
J. Am. Coll. Cardiol.,
April 14, 2009;
53(15):
e1 - e90.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
2005 WRITING COMMITTEE MEMBERS, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, et al.
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation
Circulation,
April 14, 2009;
119(14):
e391 - e479.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Yamaguchi, T. Kaneshiro, S.-i. Saitoh, T. Ishibashi, Y. Maruyama, and Y. Takeishi
Regulation of coronary vascular tone via redox modulation in the {alpha}1-adrenergic-angiotensin-endothelin axis of the myocardium
Am J Physiol Heart Circ Physiol,
January 1, 2009;
296(1):
H226 - H232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Seymour, A. A. M. Singer, M. R. Bennink, R. V. Parikh, A. Kirakosyan, P. B. Kaufman, and S. F. Bolling
Chronic Intake of a Phytochemical-Enriched Diet Reduces Cardiac Fibrosis and Diastolic Dysfunction Caused by Prolonged Salt-Sensitive Hypertension
J Gerontol A Biol Sci Med Sci,
October 1, 2008;
63(10):
1034 - 1042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Liu, L. Gao, S. K. Roy, K. G. Cornish, and I. H. Zucker
Role of Oxidant Stress on AT1 Receptor Expression in Neurons of Rabbits With Heart Failure and in Cultured Neurons
Circ. Res.,
July 18, 2008;
103(2):
186 - 193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Young, C. H. Strey, P. M. George, C. M. Florkowski, C. W. Sies, C. M. Frampton, and R. S. Scott
Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure
Eur J Heart Fail,
May 1, 2008;
10(5):
463 - 466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rohrbach, A. Martin, B. Niemann, and A. Cherubini
Enhanced myocardial vitamin C accumulation in left ventricular hypertrophy in rats is not attenuated with transition to heart failure
Eur J Heart Fail,
March 1, 2008;
10(3):
226 - 232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Banfi, M. Brioschi, S. Barcella, F. Veglia, P. Biglioli, E. Tremoli, and P. Agostoni
Oxidized proteins in plasma of patients with heart failure: Role in endothelial damage
Eur J Heart Fail,
March 1, 2008;
10(3):
244 - 251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ramasubbu, J. Estep, D. L. White, A. Deswal, and D. L. Mann
Experimental and Clinical Basis for the Use of Statins in Patients With Ischemic and Nonischemic Cardiomyopathy
J. Am. Coll. Cardiol.,
January 29, 2008;
51(4):
415 - 426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. A. Williams and D. G. Allen
The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice
Am J Physiol Heart Circ Physiol,
September 1, 2007;
293(3):
H1969 - H1977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gao, W. Wang, D. Liu, and I. H. Zucker
Exercise Training Normalizes Sympathetic Outflow by Central Antioxidant Mechanisms in Rabbits With Pacing-Induced Chronic Heart Failure
Circulation,
June 19, 2007;
115(24):
3095 - 3102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Takimoto and D. A. Kass
Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling
Hypertension,
February 1, 2007;
49(2):
241 - 248.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nojiri, T. Shimizu, M. Funakoshi, O. Yamaguchi, H. Zhou, S. Kawakami, Y. Ohta, M. Sami, T. Tachibana, H. Ishikawa, et al.
Oxidative Stress Causes Heart Failure with Impaired Mitochondrial Respiration
J. Biol. Chem.,
November 3, 2006;
281(44):
33789 - 33801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Matsui, T. Shimosawa, Y. Uetake, H. Wang, S. Ogura, T. Kaneko, J. Liu, K. Ando, and T. Fujita
Protective Effect of Potassium Against the Hypertensive Cardiac Dysfunction: Association With Reactive Oxygen Species Reduction
Hypertension,
August 1, 2006;
48(2):
225 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cohen-Solal, F. Rouzet, A. Berdeaux, D. Le Guludec, E. Abergel, A. Syrota, and P. Merlet
Effects of Carvedilol on Myocardial Sympathetic Innervation in Patients with Chronic Heart Failure
J. Nucl. Med.,
November 1, 2005;
46(11):
1796 - 1803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K.A. Witte, N. P. Nikitin, A. C. Parker, S. von Haehling, H.-D. Volk, S. D. Anker, A. L. Clark, and J. G.F. Cleland
The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure
Eur. Heart J.,
November 1, 2005;
26(21):
2238 - 2244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. de Lorgeril, P. Salen, and P. Defaye
Importance of nutrition in chronic heart failure patients
Eur. Heart J.,
November 1, 2005;
26(21):
2215 - 2217.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Cucoranu, R. Clempus, A. Dikalova, P. J. Phelan, S. Ariyan, S. Dikalov, and D. Sorescu
NAD(P)H Oxidase 4 Mediates Transforming Growth Factor-{beta}1-Induced Differentiation of Cardiac Fibroblasts Into Myofibroblasts
Circ. Res.,
October 28, 2005;
97(9):
900 - 907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Avgeropoulou, I. Andreadou, S. Markantonis-Kyroudis, M. Demopoulou, P. Missovoulos, A. Androulakis, and I. Kallikazaros
The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine
Eur J Heart Fail,
August 1, 2005;
7(5):
882 - 887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Keith and L. Errett
Myocardial Metabolism and Improved OutcomesAfter High Risk Heart Surgery
Seminars in Cardiothoracic and Vascular Anesthesia,
June 1, 2005;
9(2):
167 - 171.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Heitzer, S. Baldus, Y. von Kodolitsch, V. Rudolph, and T. Meinertz
Systemic Endothelial Dysfunction as an Early Predictor of Adverse Outcome in Heart Failure
Arterioscler Thromb Vasc Biol,
June 1, 2005;
25(6):
1174 - 1179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Stuveling, S. J. L. Bakker, H. L. Hillege, P. E. de Jong, R. O. B. Gans, and D. de Zeeuw
Biochemical risk markers: a novel area for better prediction of renal risk?
Nephrol. Dial. Transplant.,
March 1, 2005;
20(3):
497 - 508.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Jekell, A. Hossain, U. Alehagen, U. Dahlstrom, and A. Rosen
Elevated circulating levels of thioredoxin and stress in chronic heart failure
Eur J Heart Fail,
December 1, 2004;
6(7):
883 - 890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ohta, N. Hasebe, S. Tsuji, K. Izawa, Y.-T. Jin, S. Kido, S. Natori, M. Sato, and K. Kikuchi
Unequal effects of renin-angiotensin system inhibitors in acute cardiac dysfunction induced by isoproterenol
Am J Physiol Heart Circ Physiol,
December 1, 2004;
287(6):
H2914 - H2921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gao, W. Wang, Y.-L. Li, H. D. Schultz, D. Liu, K. G. Cornish, and I. H. Zucker
Superoxide Mediates Sympathoexcitation in Heart Failure: Roles of Angiotensin II and NAD(P)H Oxidase
Circ. Res.,
October 29, 2004;
95(9):
937 - 944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Coronella-Wood, J. Terrand, H. Sun, and Q. M. Chen
c-Fos Phosphorylation Induced by H2O2 Prevents Proteasomal Degradation of c-Fos in Cardiomyocytes
J. Biol. Chem.,
August 6, 2004;
279(32):
33567 - 33574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Valgimigli, E. Merli, P. Malagutti, O. Soukhomovskaia, G. Cicchitelli, A. Antelli, D. Canistro, G. Francolini, G. Macri, F. Mastrorilli, et al.
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction
J. Am. Coll. Cardiol.,
June 2, 2004;
43(11):
2000 - 2008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hokamaki, H. Kawano, M. Yoshimura, H. Soejima, S. Miyamoto, I. Kajiwara, S. Kojima, T. Sakamoto, S. Sugiyama, N. Hirai, et al.
Urinary biopyrrins levels are elevated in relation to severity of heart failure
J. Am. Coll. Cardiol.,
May 19, 2004;
43(10):
1880 - 1885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schulze P., A. Linke, N. Schoene, S. M. Winkler, V. Adams, S. Conradi, M. Busse, G. Schuler, and R. Hambrecht
Functional and morphological skeletal muscle abnormalities correlate with reduced electromyographic activity in chronic heart failure
European Journal of Cardiovascular Prevention & Rehabilitation,
April 1, 2004;
11(2):
155 - 161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Schafer, D. Fraccarollo, P. Tas, I. Schmidt, G. Ertl, and J. Bauersachs
Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism
Eur J Heart Fail,
March 1, 2004;
6(2):
151 - 159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mak and G. E. Newton
Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure
Am J Physiol Heart Circ Physiol,
February 1, 2004;
286(2):
H789 - H795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Nightingale, M. Schmitt, M. P. Frenneaux, G. Piccirillo, M. Nocco, A. Moise, M. Lionetti, C. Naso, and S. D. C. V. Marigliano
Letter: Vitamin C in Heart Failure: Hype or Hope?
Hypertension,
February 1, 2004;
e6(2):
.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Ahokas, K. J. Warrington, I. C. Gerling, Y. Sun, L. A. Wodi, P. A. Herring, L. Lu, S. K. Bhattacharya, A. E. Postlethwaite, and K. T. Weber
Aldosteronism and Peripheral Blood Mononuclear Cell Activation: A Neuroendocrine-Immune Interface
Circ. Res.,
November 14, 2003;
93(10):
e124 - e135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Peschel, M. Schonauer, H. Thiele, S. Anker, G. Schuler, and J. Niebauer
Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure
Eur J Heart Fail,
October 1, 2003;
5(5):
609 - 614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Nonaka-Sarukawa, K Yamamoto, H Aoki, H Takano, T Katsuki, U Ikeda, and K Shimada
Increased urinary 15-F2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress
Heart,
August 1, 2003;
89(8):
871 - 874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. C. Gerling, Y. Sun, R. A. Ahokas, L. A. Wodi, S. K. Bhattacharya, K. J. Warrington, A. E. Postlethwaite, and K. T. Weber
Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype
Am J Physiol Heart Circ Physiol,
July 11, 2003;
285(2):
H813 - H821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Cappola, L. Cope, A. Cernetich, L. A. Barouch, K. Minhas, R. A. Irizarry, G. Parmigiani, S. Durrani, T. Lavoie, E. P. Hoffman, et al.
Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy
Physiol Genomics,
June 24, 2003;
14(1):
25 - 34.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P Taylor, J. T Ciccolo, and J. W Starnes
Effect of exercise training on the ability of the rat heart to tolerate hydrogen peroxide
Cardiovasc Res,
June 1, 2003;
58(3):
575 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Schafer, D. Fraccarollo, S. K Hildemann, P. Tas, G. Ertl, and J. Bauersachs
Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction
Cardiovasc Res,
June 1, 2003;
58(3):
655 - 662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S.P. Chin, N. J. Langford, S. L. Nuttall, C. R. Gibbs, A. D. Blann, and G. Y.H. Lip
Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure
Eur J Heart Fail,
March 1, 2003;
5(2):
171 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Machida, T. Kubota, N. Kawamura, H. Funakoshi, T. Ide, H. Utsumi, Y. Y. Li, A. M. Feldman, H. Tsutsui, H. Shimokawa, et al.
Overexpression of tumor necrosis factor-alpha increases production of hydroxyl radical in murine myocardium
Am J Physiol Heart Circ Physiol,
February 1, 2003;
284(2):
H449 - H455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P A Henriksen and D E Newby
Therapeutic inhibition of tumour necrosis factor {alpha} in patients with heart failure: cooling an inflamed heart
Heart,
January 1, 2003;
89(1):
14 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Azeka, J. A. Franchini Ramires, C. Valler, and E. Alcides Bocchi
Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment
J. Am. Coll. Cardiol.,
December 4, 2002;
40(11):
2034 - 2038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nakamura, K. Kusano, Y. Nakamura, M. Kakishita, K. Ohta, S. Nagase, M. Yamamoto, K. Miyaji, H. Saito, H. Morita, et al.
Carvedilol Decreases Elevated Oxidative Stress in Human Failing Myocardium
Circulation,
June 18, 2002;
105(24):
2867 - 2871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tsutsui, T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, M. Hayashi, M. Ohnishi, and M. Kinoshita
Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure
J. Am. Coll. Cardiol.,
March 20, 2002;
39(6):
957 - 962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. Colombo, A. W. Ashton, S. Celaj, A. Talreja, J. E. Banchs, N. B. Dubois, M. Marinaccio, S. Malla, J. Lachmann, J. A. Ware, et al.
Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium
J Appl Physiol,
March 1, 2002;
92(3):
1331 - 1338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. C. Tu, J. J. Bahl, and Q. M. Chen
Signals of Oxidant-Induced Cardiomyocyte Hypertrophy: Key Activation of p70 S6 Kinase-1 and Phosphoinositide 3-Kinase
J. Pharmacol. Exp. Ther.,
March 1, 2002;
300(3):
1101 - 1110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. F. Saavedra, N. Paolocci, M. E. St. John, M. W. Skaf, G. C. Stewart, J.-S. Xie, R. W. Harrison, J. Zeichner, D. Mudrick, E. Marban, et al.
Imbalance Between Xanthine Oxidase and Nitric Oxide Synthase Signaling Pathways Underlies Mechanoenergetic Uncoupling in the Failing Heart
Circ. Res.,
February 22, 2002;
90(3):
297 - 304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Adamopoulos, J. Parissis, D. Karatzas, C. Kroupis, M. Georgiadis, G. Karavolias, J. Paraskevaidis, K. Koniavitou, A. J. S. Coats, and D. T. Kremastinos
Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fasligand system in patients with chronic heart failure
J. Am. Coll. Cardiol.,
February 20, 2002;
39(4):
653 - 663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bauersachs, M. Heck, D. Fraccarollo, S. K. Hildemann, G. Ertl, M. Wehling, and M. Christ
Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: Role of vascular superoxide anion formation and endothelial nitric oxide synthase expression
J. Am. Coll. Cardiol.,
January 16, 2002;
39(2):
351 - 358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mak and G. E. Newton
The Oxidative Stress Hypothesis of Congestive Heart Failure : Radical Thoughts
Chest,
December 1, 2001;
120(6):
2035 - 2046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. de Lorgeril, P. Salen, M. Accominotti, M. Cadau, J.-P. Steghens, F. Boucher, and J. de Leiris
Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure
Eur J Heart Fail,
December 1, 2001;
3(6):
661 - 669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-W. Kong, T.-G. Hsu, F.-J. Lu, W.-L. Chan, and K. Tsai
Leukocyte mitochondria depolarization and apoptosis in advanced heart failure: clinical correlations and effect of therapy
J. Am. Coll. Cardiol.,
November 15, 2001;
38(6):
1693 - 1700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shite, F. Qin, W. Mao, H. Kawai, S. Y. Stevens, and C.-s. Liang
Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy
J. Am. Coll. Cardiol.,
November 15, 2001;
38(6):
1734 - 1740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Cappola, D. A. Kass, G. S. Nelson, R. D. Berger, G. O. Rosas, Z. A. Kobeissi, E. Marban, and J. M. Hare
Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy
Circulation,
November 13, 2001;
104(20):
2407 - 2411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Rossig, J. Hoffmann, B. Hugel, Z. Mallat, A. Haase, J.-M. Freyssinet, A. Tedgui, A. Aicher, A. M. Zeiher, and S. Dimmeler
Vitamin C Inhibits Endothelial Cell Apoptosis in Congestive Heart Failure
Circulation,
October 30, 2001;
104(18):
2182 - 2187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bauersachs, I. Fleming, D. Fraccarollo, R. Busse, and G. Ertl
Prevention of endothelial dysfunction in heart failure by vitamin E: Attenuation of vascular superoxide anion formation and increase in soluble guanylyl cyclase expression
Cardiovasc Res,
August 1, 2001;
51(2):
344 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Schimke, J. Muller, F. Priem, I. Kruse, B. Schon, J. Stein, R. Kunze, G. Wallukat, and R. Hetzer
Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption
J. Am. Coll. Cardiol.,
July 1, 2001;
38(1):
178 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. V. Ennezat, S. L. Malendowicz, M. Testa, P. C. Colombo, A. Cohen-Solal, T. Evans, and T. H. LeJemtel
Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymes
J. Am. Coll. Cardiol.,
July 1, 2001;
38(1):
194 - 198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tsutamoto, A. Wada, T. Matsumoto, K. Maeda, N. Mabuchi, M. Hayashi, T. Tsutsui, M. Ohnishi, M. Sawaki, M. Fujii, et al.
Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy
J. Am. Coll. Cardiol.,
June 15, 2001;
37(8):
2086 - 2092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Khaper and P. K. Singal
Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats
J. Am. Coll. Cardiol.,
April 1, 2001;
37(5):
1461 - 1466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E Keith, K. N Jeejeebhoy, A. Langer, R. Kurian, A. Barr, B. O'Kelly, and M. J Sole
A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure
Am J Clin Nutr,
February 1, 2001;
73(2):
219 - 224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tanaka, M. Honda, and T. Takabatake
Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte
J. Am. Coll. Cardiol.,
February 1, 2001;
37(2):
676 - 685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Rossig, J. Haendeler, Z. Mallat, B. Hugel, J.-M. Freyssinet, A. Tedgui, S. Dimmeler, and A. M. Zeiher
Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol
J. Am. Coll. Cardiol.,
December 1, 2000;
36(7):
2081 - 2089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Rabkin and J. Y Kong
Nitroprusside induces cardiomyocyte death: interaction with hydrogen peroxide
Am J Physiol Heart Circ Physiol,
December 1, 2000;
279(6):
H3089 - H3100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Ellis, R. A. Anderson, D. Lang, D. J. Blackman, R. H. K. Morris, J. Morris-Thurgood, I. F. W. McDowell, S. K. Jackson, M. J. Lewis, and M. P. Frenneaux
Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy
J. Am. Coll. Cardiol.,
November 1, 2000;
36(5):
1474 - 1482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Ballinger, C. Patterson, C.-N. Yan, R. Doan, D. L. Burow, C. G. Young, F. M. Yakes, B. Van Houten, C. A. Ballinger, B. A. Freeman, et al.
Hydrogen Peroxide- and Peroxynitrite-Induced Mitochondrial DNA Damage and Dysfunction in Vascular Endothelial and Smooth Muscle Cells
Circ. Res.,
May 12, 2000;
86(9):
960 - 966.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R Gosker, E. F. Wouters, G. J van der Vusse, and A. M. Schols
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives
Am J Clin Nutr,
May 1, 2000;
71(5):
1033 - 1047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Khatta, B. S. Alexander, C. M. Krichten, M. L. Fisher, R. Freudenberger, S. W. Robinson, and S. S. Gottlieb
The Effect of Coenzyme Q10 in Patients with Congestive Heart Failure
Ann Intern Med,
April 18, 2000;
132(8):
636 - 640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Berry and A.L Clark
Catabolism in chronic heart failure
Eur. Heart J.,
April 1, 2000;
21(7):
521 - 532.
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sethi, N. Takeda, M. Nagano, and N. S. Dhalla
Beneficial Effects of Vitamin E Treatment in Acute Myocardial Infarction
Journal of Cardiovascular Pharmacology and Therapeutics,
January 1, 2000;
5(1):
51 - 58.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Paulus
How are cytokines activated in heart failure?
Eur J Heart Fail,
December 17, 1999;
1(4):
309 - 312.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Gronda and E. Vitali
Left ventricle assist systems: a possible alternative to heart transplantation for heart failure patients? Patient selection, techniques and benefit
Eur J Heart Fail,
December 17, 1999;
1(4):
319 - 325.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Li, J. A. Lawson, M. Reilly, M. Adiyaman, S.-W. Hwang, J. Rokach, and G. A. FitzGerald
Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F2-isoprostanes in human urine
PNAS,
November 9, 1999;
96(23):
13381 - 13386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Raina, J. Lamarre, C.-C. Liew, A. H. Lofti, and K. N. Jeejeebhoy
Effect of nutrition on tumor necrosis factor receptors in weight-gaining and -losing rats
Am J Physiol Endocrinol Metab,
September 1, 1999;
277(3):
E464 - E473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Kojda and D. Harrison
Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure
Cardiovasc Res,
August 15, 1999;
43(3):
652 - 671.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Flesch, C. Maack, B. Cremers, A. T. Baumer, M. Sudkamp, and M. Bohm
Effect of {beta}-Blockers on Free Radical Induced Cardiac Contractile Dysfunction
Circulation,
July 27, 1999;
100(4):
346 - 353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Munzel and D. G. Harrison
Increased Superoxide in Heart Failure : A Biochemical Baroreflex Gone Awry
Circulation,
July 20, 1999;
100(3):
216 - 218.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bauersachs, A. Bouloumie, D. Fraccarollo, K. Hu, R. Busse, and G. Ertl
Endothelial Dysfunction in Chronic Myocardial Infarction Despite Increased Vascular Endothelial Nitric Oxide Synthase and Soluble Guanylate Cyclase Expression : Role of Enhanced Vascular Superoxide Production
Circulation,
July 20, 1999;
100(3):
292 - 298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. F. Saavedra, N. Paolocci, M. E. St. John, M. W. Skaf, G. C. Stewart, J.-S. Xie, R. W. Harrison, J. Zeichner, D. Mudrick, E. Marban, et al.
Imbalance Between Xanthine Oxidase and Nitric Oxide Synthase Signaling Pathways Underlies Mechanoenergetic Uncoupling in the Failing Heart
Circ. Res.,
February 22, 2002;
90(3):
297 - 304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Thomas, W. Zhang, and R. G. Victor
Impaired Modulation of Sympathetic Vasoconstriction in Contracting Skeletal Muscle of Rats With Chronic Myocardial Infarctions : Role of Oxidative Stress
Circ. Res.,
April 27, 2001;
88(8):
816 - 823.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|